Synopsis
Synopsis
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Aftate
2. Breezee
3. Chinofungin
4. Chlorisept
5. Curatin
6. Genaspor
7. Micoisdin
8. Np 27
9. Np-27
10. Np27
11. Ony Clear
12. Ony-clear
13. Purder N, Tolnaftat
14. Sporiline
15. Tinactin
16. Tinaderm
17. Tinatox
18. Tineafax
19. Ting
20. Tolnaftat Purder N
21. Tonoftal
22. Zeasorb
1. 2398-96-1
2. Tinactin
3. Tonoftal
4. Tolnaphthate
5. Sporiline
6. Tinaderm
7. Tolsanil
8. Aftate
9. Chinofungin
10. Dermoxin
11. Focusan
12. Tinavet
13. Pitrex
14. Naphthiomate T
15. Phytoderm
16. Timoped
17. Tritin
18. Hi-alazin
19. Fungistop
20. Tolnaftato
21. Tolnaftatum
22. Separin
23. Sorgoa
24. Sch 10144
25. O-2-naphthyl M,n-dimethylthiocarbanilate
26. Dungistop
27. Tniaderm
28. Naphthiomate-t
29. Hi-alarzin
30. 2-naphthyl N-methyl-n-(3-tolyl)thionocarbamate
31. M,n-dimethylthiocarbanilic Acid O-2-naphthyl Ester
32. O-naphthalen-2-yl N-methyl-n-(3-methylphenyl)carbamothioate
33. Prestwick_472
34. Dr. Scholl's Athlete's Foot Spray
35. Methyl (3-methylphenyl)carbamothioic Acid O-2-naphthalenyl Ester
36. Carbamothioic Acid, Methyl(3-methylphenyl)-, O-2-naphthalenyl Ester
37. Carbanilic Acid, M,n-dimethylthio-, O-2-naphthyl Ester
38. Carbanilic Acid, N,m-dimethylthio-, O-2-naphthyl Ester
39. Nsc 233648
40. Mls000028526
41. N-methyl-n-(3-methylphenyl)-1-naphthalen-2-yloxy-methanethioamide
42. O-naphthalen-2-yl N-methyl-n-(3-methylphenyl)thiocarbamate
43. Nsc-233648
44. Smr000058288
45. 06kb629tkv
46. Chebi:9620
47. Tolnaftato [dcit]
48. O-naphthalen-2-yl Methyl(m-tolyl)carbamothioate
49. O-2-naphthyl Methyl(3-methylphenyl)carbamothioate
50. Sch-10144
51. Tolnaftatum [inn-latin]
52. Ncgc00016610-01
53. Tolnaftato [inn-spanish]
54. Tinavet (veterinary)
55. Genaspore Cream
56. Tinactin Powder
57. Cas-2398-96-1
58. Tinactin Cream
59. Pitrex Cream
60. N-methyl-n-(3-methylphenyl)-1-(naphthalen-2-yloxy)methanethioamide
61. Ting Products
62. Tinactin Solution
63. Carbamothioic Acid, N-methyl-n-(3-methylphenyl)-, O-2-naphthalenyl Ester
64. Dsstox_cid_22477
65. Dsstox_rid_80034
66. Zeasorb-af Powder
67. Dsstox_gsid_42477
68. Tinactin (tn)
69. Separin (tn)
70. Np-27 Solution
71. Tinactin Plus Powder
72. Ting Antifungal Cream
73. Np-27 Powder
74. Ting Antifungal Powder
75. Np-27 Cream
76. Tinactin Aerosol Liquid
77. Tinactin Aerosol Powder
78. Np-27 Spray Powder
79. Tinactin Jock Itch Cream
80. Aftate For Jock Itch Gel
81. Tinactin Plus Aerosol Powder
82. Ting Antifungal Spray Liquid
83. Ting Antifungal Spray Powder
84. Aftate For Athlete's Foot Gel
85. Tolnafrate
86. Tinactin Jock Itch Spray Powder
87. Tinactin Jock Itch Aerosol Powder
88. Sr-01000003084
89. Aftate For Jock Itch Sprinkle Powder
90. Einecs 219-266-6
91. Brn 2752620
92. Tolnoftate
93. Unii-06kb629tkv
94. Tolnaflate
95. O-2-naphthyl N,n-dimethylthiocarbanilate
96. Aftate For Jock Itch Aerosol Spray Powder
97. Tinactin Antifungal Deodorant Powder Aerosol
98. Methyl-(3-methylphenyl)carbamothioic Acid O-2-naphthyl Ester
99. Tolnaftate-10kg
100. Carbamothiolic Acid
101. O-2-naphthyl Methyl(3-methylphenyl)thiocarbamate
102. Mfcd00056611
103. O-naphthalen-2-yl Methyl(3-methylphenyl)carbamothioate
104. Tolnaftate [usan:usp:inn:ban:jan]
105. Spectrum_000963
106. N-dimethylthiocarbanilate
107. Tolnaftate [mi]
108. Tolnaftate [inn]
109. Tolnaftate [jan]
110. Opera_id_1698
111. Prestwick0_000070
112. Prestwick1_000070
113. Prestwick2_000070
114. Prestwick3_000070
115. Spectrum2_000950
116. Spectrum4_000360
117. Spectrum5_001000
118. Tolnaftate [inci]
119. Tolnaftate [usan]
120. Tolnaftate [vandf]
121. Cid_5510
122. Schembl3520
123. Tolnaftate [mart.]
124. Tolnaftate [usp-rs]
125. Tolnaftate [who-dd]
126. Bspbio_000259
127. Kbiogr_000799
128. Kbioss_001443
129. Mls001146910
130. O-(2-naphthyl) N-methyl-n-(m-tolyl)carbamothioate
131. Chembl83668
132. Divk1c_000334
133. Spectrum1500583
134. Spbio_000920
135. Spbio_002180
136. Bpbio1_000285
137. Tolnaftate (jp17/usp/inn)
138. Tolnaftate [green Book]
139. Dtxsid3042477
140. Bdbm39349
141. Hms501a16
142. Kbio1_000334
143. Kbio2_001443
144. Kbio2_004011
145. Kbio2_006579
146. Tolnaftate For System Suitability
147. Zinc57522
148. Tolnaftate [ep Monograph]
149. Ninds_000334
150. Hms1568m21
151. Hms1921e21
152. Hms2092o05
153. Hms2095m21
154. Hms2231o21
155. Hms3373p10
156. Hms3655d15
157. Hms3712m21
158. Pharmakon1600-01500583
159. Tolnaftate [usp Monograph]
160. Amy23403
161. Bcp12071
162. Hy-b0370
163. Tox21_110521
164. Tox21_301363
165. N-methyl-(3-methylphenyl)-carbamothioic Acid, O-2-naphthalenyl Ester
166. Nsc233648
167. Nsc757355
168. S2058
169. Stl069548
170. Akos005111014
171. Tox21_110521_1
172. Ac-5548
173. Ccg-212827
174. Db00525
175. Ks-5115
176. Nsc-757355
177. Idi1_000334
178. Ncgc00016610-02
179. Ncgc00016610-03
180. Ncgc00016610-04
181. Ncgc00016610-05
182. Ncgc00016610-07
183. Ncgc00016610-08
184. Ncgc00023506-03
185. Ncgc00255761-01
186. Carbamothioic Acid, O-2-naphthalenyl Ester
187. Sbi-0051538.p002
188. Db-046313
189. Ab00052111
190. Ft-0603605
191. Sw196682-3
192. T3059
193. D00381
194. H10435
195. O-naphthalen-2-ylmethyl(m-tolyl)carbamothioate
196. Ab00052111_17
197. Ab00052111_18
198. 398t961
199. A817026
200. O-(naphthalen-2-yl) Methyl(m-tolyl)carbamothioate
201. Q415238
202. Carbanilic Acid,m-dimethylthio-, O-2-naphthyl Ester
203. Carbanilic Acid,n-dimethylthio-, O-2-naphthyl Ester
204. Sr-01000003084-2
205. Sr-01000003084-4
206. W-107363
207. Brd-k44273375-001-04-5
208. Brd-k44273375-001-14-4
209. Brd-k44273375-001-23-5
210. O-(2-naphthyl) Methyl(3-methylphenyl)thiocarbamate #
211. Methyl(3-methylphenyl)carbamothioic Acid O-2-naphthyl Ester
212. N-methyl-n-(m-tolyl)thiocarbamic Acid O-(2-naphthyl) Ester
213. Tolnaftate, European Pharmacopoeia (ep) Reference Standard
214. Tolnaftate, United States Pharmacopeia (usp) Reference Standard
215. Methyl-[3-methyl-2-(2-naphthyl)phenyl]carbamothioic S-acid;tolnaftate
216. N-methyl-n-(3-methylphenyl)carbamothioic Acid O-(2-naphthalenyl) Ester
217. Tolnaftate, Pharmaceutical Secondary Standard; Certified Reference Material
218. Tinactin Pound>>tinaderm Pound>>aftate Pound>>np-27 Pound>>np 27 Pound>> Np27
219. Tolnaftate For System Suitability, European Pharmacopoeia (ep) Reference Standard
Molecular Weight | 307.4 g/mol |
---|---|
Molecular Formula | C19H17NOS |
XLogP3 | 5.5 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 3 |
Exact Mass | 307.10308534 g/mol |
Monoisotopic Mass | 307.10308534 g/mol |
Topological Polar Surface Area | 44.6 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 386 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Tolnaftate topical is used to treat skin infections such as athlete's foot, jock itch, and ringworm infections. Tolnaftate is also used, along with other antifungals, to treat infections of the nails, scalp, palms, and soles of the feet. The powder and powder aerosol may be used to prevent athlete's foot.
Tolnaftate is a synthetic over-the-counter anti-fungal agent.
Antifungal Agents
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)
D - Dermatologicals
D01 - Antifungals for dermatological use
D01A - Antifungals for topical use
D01AE - Other antifungals for topical use
D01AE18 - Tolnaftate
Tolnaftate is a topical fungicide. Though its exact mechanism unknown, it is believed to prevent ergosterol biosynthesis by inhibiting squalene epoxidase. It has also been reported to distort the hyphae and to stunt mycelial growth in susceptible organisms.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5796
Submission : 1985-04-03
Status : Active
Type : II
NDC Package Code : 12780-4800
Start Marketing Date : 1985-04-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26761
Submission : 2012-12-20
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3041
Submission : 1977-10-24
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3087
Submission : 1977-11-22
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5427
Submission : 1984-07-09
Status : Inactive
Type : II
Date of Issue : 2019-08-09
Valid Till : 2022-08-08
Written Confirmation Number : WC-253
Address of the Firm :
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Tolnaftate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tolnaftate, including repackagers and relabelers. The FDA regulates Tolnaftate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tolnaftate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tolnaftate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tolnaftate supplier is an individual or a company that provides Tolnaftate active pharmaceutical ingredient (API) or Tolnaftate finished formulations upon request. The Tolnaftate suppliers may include Tolnaftate API manufacturers, exporters, distributors and traders.
click here to find a list of Tolnaftate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tolnaftate DMF (Drug Master File) is a document detailing the whole manufacturing process of Tolnaftate active pharmaceutical ingredient (API) in detail. Different forms of Tolnaftate DMFs exist exist since differing nations have different regulations, such as Tolnaftate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tolnaftate DMF submitted to regulatory agencies in the US is known as a USDMF. Tolnaftate USDMF includes data on Tolnaftate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tolnaftate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tolnaftate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Tolnaftate Drug Master File in Japan (Tolnaftate JDMF) empowers Tolnaftate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Tolnaftate JDMF during the approval evaluation for pharmaceutical products. At the time of Tolnaftate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Tolnaftate suppliers with JDMF on PharmaCompass.
A Tolnaftate CEP of the European Pharmacopoeia monograph is often referred to as a Tolnaftate Certificate of Suitability (COS). The purpose of a Tolnaftate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Tolnaftate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Tolnaftate to their clients by showing that a Tolnaftate CEP has been issued for it. The manufacturer submits a Tolnaftate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Tolnaftate CEP holder for the record. Additionally, the data presented in the Tolnaftate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Tolnaftate DMF.
A Tolnaftate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Tolnaftate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Tolnaftate suppliers with CEP (COS) on PharmaCompass.
A Tolnaftate written confirmation (Tolnaftate WC) is an official document issued by a regulatory agency to a Tolnaftate manufacturer, verifying that the manufacturing facility of a Tolnaftate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Tolnaftate APIs or Tolnaftate finished pharmaceutical products to another nation, regulatory agencies frequently require a Tolnaftate WC (written confirmation) as part of the regulatory process.
click here to find a list of Tolnaftate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tolnaftate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tolnaftate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tolnaftate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tolnaftate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tolnaftate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tolnaftate suppliers with NDC on PharmaCompass.
Tolnaftate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tolnaftate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tolnaftate GMP manufacturer or Tolnaftate GMP API supplier for your needs.
A Tolnaftate CoA (Certificate of Analysis) is a formal document that attests to Tolnaftate's compliance with Tolnaftate specifications and serves as a tool for batch-level quality control.
Tolnaftate CoA mostly includes findings from lab analyses of a specific batch. For each Tolnaftate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tolnaftate may be tested according to a variety of international standards, such as European Pharmacopoeia (Tolnaftate EP), Tolnaftate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tolnaftate USP).
LOOKING FOR A SUPPLIER?